🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators believe that administering Dupilumab during the pre- and ...
Status
Completed
Location
Centre Hospitalier de l'Université de Montréal (CHUM)
Start Date
2021-05-25
Trial ID
NCT04596189
Treatments Being Tested
EFC18418 is a multinational, randomized, double-blind, placebo-controlled, ...
Status
Active Not Recruiting
Location
University of Southern California (USC) / Keck Medicine of USC- Site Number : 8400037
Start Date
2025-02-12
Trial ID
NCT06834347
Treatments Being Tested
This study will evaluate the effectiveness and safety of MFNS in improving ...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01386125
Treatments Being Tested
This study seeks to prospectively demonstrate that Nasonex is better than p...
Status
Completed
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT00732381
Treatments Being Tested
This study will hope to show that by relieving the participant's nasal symp...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00358527
Treatments Being Tested
The purpose of this study is to evaluate how well mometasone furoate nasal ...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT00491504
Treatments Being Tested
The primary purpose of the study is to evaluate the efficacy of brensocatib...
Status
Completed
Location
USA034
Start Date
2023-10-30
Trial ID
NCT06013241
Treatments Being Tested
This study seeks to prospectively demonstrate that Nasonex is better than p...
Status
Completed
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT00728416
Treatments Being Tested
This study was conducted to evaluate the effectiveness of mometasone nasal ...
Status
Completed
Location
Multiple Locations
Start Date
2003-09-01
Trial ID
NCT00731185
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab (SAR231893/REGN66...
Status
Completed
Location
Investigational Site Number 840014
Start Date
2013-08
Trial ID
NCT01920893
Treatments Being Tested